Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Letter to the Shareholders - LL
3
Sep 23, 2008 06:22AM

"Our recent preliminary proxy filing in its original form also created some confusion as to the apparent increase of approximately 20 million shares as of August 29th, compared to the outstanding shares as disclosed in recent, previous public filings. These shares were, in fact, part of the consideration for the Crossflo transaction and were technically issued by our Transfer Agent as of the closing of the transaction on August 29th."

Gosh, I guess you were wrong. Happens to the best of us....

SGE

1
Sep 23, 2008 03:46PM
1
Sep 24, 2008 11:58AM
Share
New Message
Please login to post a reply